Physical Activity and Cerebral Metabolism in the Elderly: a Randomised Controlled Trial (SMART)

August 31, 2015 updated by: Professor Johannes Pantel
Physical activity exerts a variety of long-term health benefits in older adults.This randomised controlled trial investigates the effect of a 12-week physical exercise program on the change in cerebral metabolism as assessed with Magnetic Resonance Spectroscopic Imaging. Follow-up lasts for 6 months.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Frankfurt am Main, Germany, 60487
        • Department of Sports Medicine, Institute of Sports Sciences, Goethe University
      • Frankfurt am Main, Germany, 60590
        • Institute of General Practice, Goethe University,

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. be above 65 years of age,
  2. voluntariness
  3. capacity to consent,
  4. having passed medical entry exam by the Department of Sports Medicine,

4) regular mental capacity, 5) written informed consent

Exclusion Criteria:

  1. untreated clotting disorders,
  2. musculoskeletal diseases significantly reducing mobility,
  3. severe bacterial or viral infections,
  4. severe respiratory diseases (Gold IV),
  5. acute pulmonary embolism,
  6. instable angina pectoris or severe heart failure (NYHA III or IV),
  7. severe vascular disease of the extremities or the brain,
  8. severe pulmonary-cardiac dysfunction,
  9. acute myocardial infarction or early phase of rehabilitation,
  10. critical aortal stenosis,
  11. severe hypertrophic and obstructive cardiomyopathy,
  12. untreated malignant arrhythmias,
  13. untreated severe hypertonia,
  14. severe pulmonary hypertonia,
  15. symptomatic cardiac malformations,
  16. cardiac-block grade II or III,
  17. left bundle branch block,
  18. complex ventricular arrhythmias,
  19. Cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Participants in the Intervention group exercise three times a week for 30 minutes on a bicycle ergometer (optibike med, ergoline GmbH, Bitz, Germany) in the integrated gym hall of one of the participating residencies. Training is individualised as respective performance is adapted to the power at the first ventilator threshold (assessed during cardiopulmonary exercise test).
During the first 4 weeks of intervention two of the three weekly training sessions are offered as group training supervised by the respective qualified exercise physiologist of the Department of Sports Medicine. After 4 weeks, participants' physical performance is reassessed at the Department of Sports Medicine. If necessary, workload is readjusted to achieve the initially defined exercise intensity.
Active Comparator: Waiting Control
Participants of Waiting Control continue their regular physical activity behaviour for 12 weeks. They will start the same exercise intervention after a reassessment at week 12 for the next upcoming 12 weeks. (13-24)
During the first 4 weeks of intervention two of the three weekly training sessions are offered as group training supervised by the respective qualified exercise physiologist of the Department of Sports Medicine. After 4 weeks, participants' physical performance is reassessed at the Department of Sports Medicine. If necessary, workload is readjusted to achieve the initially defined exercise intensity.
After waiting for 12 weeks with normal daily activity, patients are allocated to a individualised aerobic exercise training, too.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cerebral metabolism (assessed by MRSI)
Time Frame: 6 month

assessed by MRSI, Primary hypothesis is that aerobic exercise leads to an increase of cerebral N-acetyl-aspartate (NAA; mediated by plasma neurotrophins).

Secondary hypothesis stipulates an increase of markers of neuronal energy reserve: i.e. the ratio of phosphocreatinin to creatinine and of adenosine-tri-phosphate (ATP) to ~di-phosphate (ADP).

Third hypothesis is an increase in the volume of cortical grey matter

6 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cardiopulmonary exercise test (Aerobic exercise capacity is determined by a physician-supervised CPET)
Time Frame: 0, 3 and 6 month
Aerobic exercise capacity is determined by a physician-supervised CPET
0, 3 and 6 month
Psychometric testing 1 (verbal declarative memory [Verbal Learning and Memory test; adapted German version of the Rey Auditory Verbal Learning test]
Time Frame: 0, 3 and 6 month
verbal declarative memory [Verbal Learning and Memory test; adapted German version of the Rey Auditory Verbal Learning test]
0, 3 and 6 month
Psychometric testing 2 (frontal executive control [Colour-Word-Interference test; adapted German version of the Stroop test; Trail-Making-Test Part B]
Time Frame: 0, 3 and 6 month
frontal executive control [Colour-Word-Interference test; adapted German version of the Stroop test; Trail-Making-Test Part B]
0, 3 and 6 month
Psychometric testing 3 (working memory [Digit Span Test forward and backward]
Time Frame: 0, 3 and 6 month
working memory [Digit Span Test forward and backward]
0, 3 and 6 month
Psychometric testing 4 9semantic and phonematic fluency, nonverbal declarative memory and visual-constructive abilities by means of the CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychological Battery)
Time Frame: 0, 3 and 6 month
semantic and phonematic fluency, nonverbal declarative memory and visual-constructive abilities by means of the CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychological Battery
0, 3 and 6 month
Psychometric testing 5 (speed of cognitive processing is assessed by means of the Trail-Making-Test Part A)
Time Frame: 0, 3 and 6 month
speed of cognitive processing is assessed by means of the Trail-Making-Test Part A
0, 3 and 6 month
Psychometric testing 6 (depressive disorders: Geriatric Depression Scale)
Time Frame: 0, 3 and 6 month
depressive disorders: Geriatric Depression Scale
0, 3 and 6 month
Psychometric testing 7 (Age-associated subjective memory impairment is assessed using a memory complaint questionnaire [MAC-Q]
Time Frame: 0, 3 and 6 month
Age-associated subjective memory impairment is assessed using a memory complaint questionnaire [MAC-Q]
0, 3 and 6 month
Psychometric testing 8 (cristalline intelligence is assessed by means of a verbal intelligence test [Multiple-Choice Word Test: MWT-B]
Time Frame: 0, 3 and 6 month
cristalline intelligence is assessed by means of a verbal intelligence test [Multiple-Choice Word Test: MWT-B]
0, 3 and 6 month
Psychometric testing 9 (dementia and mild cognitive impairment using the Mini Mental State Examination and the Instrumental Activities of Daily Living Questionnaire)
Time Frame: 0, 3 and 6 month
dementia and mild cognitive impairment using the Mini Mental State Examination and the Instrumental Activities of Daily Living Questionnaire
0, 3 and 6 month
Balance and strength (postural sway (balance) and gait data acquisition via the capacitive force-measuring platform (30 Hz) WinFDM v0.0.41® (Zebris© GmbH, Isny, Germany)
Time Frame: 0, 3 and 6 month
postural sway (balance) and gait data acquisition via the capacitive force-measuring platform (30 Hz) WinFDM v0.0.41® (Zebris© GmbH, Isny, Germany)
0, 3 and 6 month
Pain Assessment (German Pain Questionnaire)
Time Frame: 0, 3 and 6 month
German Pain Questionnaire
0, 3 and 6 month
History of diet (Food frequency questionnaire DEGS1)
Time Frame: 0, 3 and 6 month
Food frequency questionnaire DEGS1
0, 3 and 6 month
History and fear of falling (German version of the Falls-Efficacy-Scale International Version)
Time Frame: 0, 3 and 6 month
German version of the Falls-Efficacy-Scale International Version
0, 3 and 6 month
Physical activity (International Physical Activity Questionnaire, Lifetime Total Physical Activity Questionnaire and Accelerometry)
Time Frame: 0, 3 and 6 month
International Physical Activity Questionnaire, Lifetime Total Physical Activity Questionnaire and Accelerometry
0, 3 and 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Johannes Pantel, Prof., Institute of General Practice, Goethe University, Frankfurt/Main, Germany
  • Principal Investigator: Winfried E Banzer, Prof., Department of Sports Medicine, Institute of Sports Sciences, Goethe University, Frankfurt/Main, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2014

Primary Completion (Actual)

August 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

January 12, 2015

First Submitted That Met QC Criteria

January 20, 2015

First Posted (Estimate)

January 21, 2015

Study Record Updates

Last Update Posted (Estimate)

September 2, 2015

Last Update Submitted That Met QC Criteria

August 31, 2015

Last Verified

August 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Individualised aerobic exercise training

3
Subscribe